Evaluation the Efficacy "Think and Cope Positively" Program (PA+)
Mental Disorder

About this trial
This is an interventional treatment trial for Mental Disorder focused on measuring Schizophrenia, Subjective Well-Being, Optimism, Coping, Purpose of life
Eligibility Criteria
Inclusion Criteria: Users of public psychosocial rehabilitation resources belonging to the Community of Madrid and Castilla la Mancha Legal age Clinical diagnosis of severe mental disorder: schizophrenia spectrum, bipolar disorder, personality disorders and severe affective disorders. Psychopathological stability (or that residual symptoms do not interfere with the course of treatment) Minimum level of cognitive comprehension (i.e. no comorbidity with intellectual disability). Exclusion Criteria: Addiction dependence criteria (on the other hand, people with substance abuse criteria will be accepted) Altered behavior (relationally) that could alter the good functioning of the group. Prior to their participation in the study, the rehabilitation team, in coordination with the research team, will assess whether the patient can benefit from the study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Other
TAU + Wellbeing promotion group (Think and Cope Positively) Intervention
TAU + waiting list
In addition to their usual treatment, participants form the experimental arm will receive 15 weekly intervention sessions, where aspects related to subjective wellbeing, life plans, alliance with the therapist or family and social relationships will be worked on.
The control group will continue to receive the treatment as usual in their intervention resources. At the end of the 15-week control period they will receive the intervention.